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The apical junctional complexes, roles, and dysfunctionsIn multicellular organisms, epithelial barriers, which promote
organ homeostasis by restricting the ﬂow of ions and solutes between
cells, are fundamental to the physiology of organ systems. Epithelia
form diffusion barriers between cellular compartments of very
different ﬂuid and solute composition through both asymmetrically
distributed transcellular transport mechanisms (transcellular path-
way) and also by structures that regulate the diffusion of ions and
small, noncharged solutes through the paracellular pathway. At the
apical end of the paracellular space, adjacent cell membranes are
indeed in close apposition, a site that was termed by early anatomists
as the “terminal bar.” These intercellular junctional complexes are
composed of the tight junctions or zonula occludens, the adherens
junctions or zonula adherens, and desmosomes or macular adherens,
whereas gap junctions provide for intercellular communication. Tight
junctions (TJs) form an intercellular diffusion gate regulating the
passage of ions, water, and various macromolecules through the
paracellular spaces, and a fence restricting the apical/basolateral
diffusion of membrane proteins and lipids whereas adherens junc-
tions and desmosomes link membrane and cytoskeletal components
at discrete contact regions. The present issue of Biochimica et
Biophysica Acta “Biomembranes” and the companion issue “The apical
junctional complexes, composition, structure and characteristics”
(Biochim. Biophys. Acta 1778 (3), 2008) were designed to summarize
the main aspects of the state of the art on the characteristics,
composition, structure, and roles of the apical junctional complexes as
well as some of the consequences of their dysfunctions.
The polarized architecture of epithelial cells and tissues is a
fundamental determinant of animal anatomy and physiology, and
mammalian epithelial tumors for example appear to lose polarity as
they progress toward malignancy. Drosophila melanogaster is a geneti-
cally simplemodel, particularly suited to examinehowaproper epithelial
architecture is intimately involved in a cell's ability to control its growth.
Badouel and McNeill [1] explore the links between growth and apical
junction proteins in the regulation of growth control in this model.
Several submembranous components of apical junctional complexes
are able to inﬂuence gene expression through their nuclear shuttling or
their speciﬁc binding to transcription factors. Balda and Matter [2]
describehow tight junctionproteinsparticipate in the regulation of gene
expression and cell proliferation, as well as how they are regulated
themselves by different mechanisms involved in gene expression and
cell differentiation. Tight-junction-associated signaling pathways are
deregulated in cancer cells but whether these changes are a cause or
consequence of transformation remains to be elucidated.
The different types of intercellular junctions (tight, anchoring and
gap junctions), sharing common adaptor molecules (particularly
zonula occludens-1), frequently present intermingled relationships,
their proteins coassemble into macromolecular complexes, and their
expressions are coordinately regulated. Derangeon et al. [3] present an0005-2736/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2009.03.001overview of these intimate spatial relationships between the different
types of junctions (well conserved through evolution) and highlight
the physiological importance of such protein–protein interactions in
intercellular junction functions.
Integrins comprise a large family of cell adhesion molecules that
mediate interactions between the extracellular environment and the
cytoplasm. The analysis of the expression and functions of these
molecules has revealed their importance in the regulation of many
aspects of cell behavior, including cell death, proliferation, migration,
and differentiation. Johnson et al. [4] summarize the current under-
standing of integrin involvement in skeletal muscle formation and
discuss what conclusions can be drawn about integrin function by
studying the evolutionary conservation of integrins.
Small GTP-binding proteins (G proteins) aremolecular switches that
control a wide variety of signal transduction pathways in all eukaryotic
cells. More than 100 small G proteins have been identiﬁed, with slightly
different structures and mechanisms of action. They are classiﬁed into
several main families (Ras, Rho, Rab, Rap, Arf, Ran, Rheb, Rad, and Rit),
eachofwhichbeing furtherdivided into subfamilies. Pannekoeket al. [5]
highlight the latest ﬁndings on the Rap signaling network in both de
novo formation and dynamic regulation of intercellular junctions,where
several Rap guanine nucleotide exchange factors (RapGEFs) function to
activate Rap. Popoff andGeny [6] examine the important roles played by
Rho/Ras GTPase in the regulation of TJs via the contraction of apical
acto-myosin ﬁlaments and of Rac/Cdc42 in the coordination of
assembly-disassembly of AJ components, and the reciprocal inﬂuence
on the integrity of intercellular junctions on the activities of G-proteins,
particularly Rho-GTPases.
TJ functions are essential for the development and physiological
functions of organs but appropriate experimental methods to
investigate their in vivo importance were lacking until their molecular
components were identiﬁed. Targeted gene inactivations (commonly
known as gene knockout) are currently employed to study the
functional importance of speciﬁc genes and proteins and the impact of
speciﬁc genetic mutations and deletions on complex metabolic
processes and their involvement in various diseases. Furuse [7]
summarizes the available data on pathologies of knockout or knock-
down mice and natural mutations of the genes of TJ-associated
structural proteins and discusses the roles of TJs in vivo.
In epithelial and endothelial cells, the term “polarity” refers to an
asymmetric distribution of macromolecules (proteins, lipids and
carbohydrates) within a cell resulting in the plasma membrane to the
subdivision into apical and basolateral domains and, within each of
these domains, by the existence of smaller, submicrometer-sized,
domains formed by segregation of plasma membrane proteins and
lipids. Giepmans and van Ijzendoorn [8] overview the functional
interrelationship between these diverse plasma membrane microdo-
mains and their formation, and address emerging cross-talk between
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polarity and architecture.
Epithelia constitute one of the primary physical barriers that
protect the organism against infectious agents in the environment.
Their integrity is maintained by intercellular junctional complexes
whose number of components are targets and/or receptors for factors
expressed and/or released by viruses, bacteria, or parasites to alter the
structure and function of the TJ barrier, to induce ﬂuid and electrolyte
secretion, or to activate the inﬂammatory cascade, for example.
Guttman and Finlay [9] overview the clever strategies developed by
these pathogens to bypass the TJ barrier. At the same time, speciﬁc
strategies used by pathogens and their virulence factors represent
very useful tools to identify novel TJ protein functions.
The blood-brain barrier (BBB), formed by the endothelial cells that
line cerebral microvessels, plays important roles in maintaining a
precisely regulated microenvironment for reliable neuronal signaling.
Any minor defect or imbalance of the BBB integrity is known to result
in serious maladies with important social impacts (e.g., multiple
sclerosis, stroke, brain tumors, epilepsy, or Alzheimer's disease).
Weiss et al. [10] focus on the implication of brain endothelial tight
junctions in BBB architecture and physiology, discuss the conse-
quences of BBB dysfunction in these CNS diseases, and present some
therapeutic strategies for drug delivery to the brain across the BBB.
The major role of the renal tubule is to alter the volume and
composition of the glomerular ﬁltrate in accordance with the
homeostatic needs of the body, thereby transforming tubular ﬂuid
into urine. The nephron exhibits considerable heterogeneity in the
permeability properties of its different segments, mainly determined
by a class of transmembrane proteins known as claudins, which form
both the barrier and the pore of the paracellular pathway. Balkovetz
[11] discusses early observations of renal tubule paracellular transport
and more recent information on the discovery of the claudin
associated membrane proteins and how they relate to normal renal
function as well as diseases of the human kidney.
TJs represent diffusion barrier by tight control of the transcellular
and paracellular pathways; this is accomplished by asymmetrical
distribution of transporters and channels for the transcellular route,
and by regulation of diffusion through the paracellular space via the
formation of ion selective pores within the TJ strands. Many cytokines
have been shown to inﬂuence epithelial and endothelial TJ function
and the actin cytoskeleton both in vivo and in vitro. Capaldo and
Nusrat [12] provide an overview of the inﬂuence of cytokines on TJ
functions, of their contribution to different pathologic conditions, and
of the involved molecular mechanisms.
Cancers encompass a broad category of diseases that arise as a
result of the accumulation of mutations, chromosomal instabilities,
and epigenetic changes that together impair the cell's system of cell
growth and death. An important step in the formation of cancer
metastases is interaction and penetration of the vascular endothelium
by dissociated cancer cells. TJs are therefore the ﬁrst barrier that
cancer cells must overcome in order to metastasize. Martin and Jiang
[13] summarize the recent progress in elucidating the role of TJ in the
invasion and metastasis of cancer via changes in barrier function due
to modulations in the expression of TJ proteins and alterations in the
structure of the TJ itself.
Therapeutic agents frequently need, in order to reach their target,
to cross epithelial and endothelial barriers via either transcellular or
paracellular pathways. The former is taken by lipophilic drugs and by
molecules selectively transported by channels, pumps, and carriers
present in the plasma membrane whereas hydrophilic molecules,
unable to cross biological membranes, have their paracellular ﬂux
markedly limited. Deli [14] presents the methods, molecules, and
excipients investigated for the safe and reversible opening of thesejunctions to enhance drug absorption and penetration. For a long time,
low efﬁciency and high toxicity prevented these approaches to be
useful for pharmaceutical therapy but new TJ modulators, designed to
directly interact with TJ proteins or regulating molecules, are
promising candidates to improve drug delivery.
I wish to thank all authors and co-authors of both issues for their
commitment and the anonymous reviewers who contributed by their
critical constructive remarks to the excellence of these issues. Lots of
thanks to Prof. Gianfranco Bazzoni (Istituto di Ricerche Farmacologiche
Mario Negri, Milan, Italy) who, by his thorough knowledge of this ﬁeld,
his suggestions, and opinions, provided an invaluable help for the
preparationof this project.Many thanksalso toDrs.Maria BaldaandKarl
Matter (University College of London, UK) for their very precious help
and suggestions.
References
[1] C. Badouel, H. McNeill, Apical junctions and growth control inDrosophila, Biochim.
Biophys. Acta 1788 (2009) 755–760.
[2] M.S. Balda, K. Matter, Tight junctions and the regulation of gene expression,
Biochim. Biophys. Acta 1788 (2009) 761–767.
[3] M. Derangeon, D.C. Spray, N. Bourmeyster, D. Sarrouilhe, J.C. Hervé, Reciprocal
inﬂuence of connexins and apical junction proteins on their expressions and
functions, Biochim. Biophys. Acta 1788 (2009) 768–778.
[4] M.S. Johnson, N. Lu, K. Denessiouk, J. Heino, D. Gullberg, Integrins during
evolution: evolutionary trees and model organisms, Biochim. Biophys. Acta 1788
(2009) 779–789.
[5] W.J. Pannekoek, M.R.H. Kooistra, F.J.T. Zwartkruis, J.L. Bos, Cell–cell junction
formation: The role of Rap1 and Rap1 guanine nucleotide exchange factors,
Biochim. Biophys. Acta 1788 (2009) 790–796.
[6] M.R. Popoff, B. Geny, Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular
junctions, Biochim. Biophys. Acta 1788 (2009) 797–812.
[7] M. Furuse, Knockout animals and natural mutations as experimental and
diagnostic tool for studying tight junction functions in vivo, Biochim. Biophys.
Acta 1788 (2009) 813–819.
[8] B.N. Giepmans, S.C. van Ijzendoorn, Epithelial cell–cell junctions and plasma
membrane domains, Biochim. Biophys. Acta 1788 (2009) 820–831.
[9] J.A. Guttman, B.B. Finlay, Tight junctions as targets of infectious agents, Biochim.
Biophys. Acta 1788 (2009) 832–841.
[10] N. Weiss, F. Miller, S. Cazaubon, P.O. Couraud, The blood–brain barrier in brain
homeostasis and neurological diseases, Biochim. Biophys. Acta 1788 (2009)
842–857.
[11] D.F. Balkovetz, Tight junction claudins and the kidney in sickness and in health,
Biochim. Biophys. Acta 1788 (2009) 858–863.
[12] C.T. Capaldo, A. Nusrat, Cytokine regulation of tight junctions, Biochim. Biophys.
Acta 1788 (2009) 864–871.
[13] T.A. Martin, W.G. Jiang, Loss of tight junction barrier function and its role in cancer
metastasis, Biochim. Biophys. Acta 1788 (2009) 872–889.
[14] M.A. Deli, Potential use of tight junction modulators to reversibly open
membranous barriers and improve drug delivery, Biochim. Biophys. Acta 1788
(2009) 892–910.
Jean-Claude Hervé
Interactions et Communications Cellulaires,
UMR CNRS 6187, PBS, 40 avenue du R. Pineau,
86022 POITIERS Cédex, France
